Atlas Trials

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

Clinical trial NCT04559529 · COMPLETED

Trial details

NCT number
NCT04559529
Sponsor
Vanderbilt University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia; Psychosis
Start date
2020-09-23
Primary completion
2023-12-31
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.